Basolateral glycylsarcosine (Gly-Sar) transport in Caco-2 cell monolayers is pH dependent

Journal of Pharmacy and Pharmacology

Volumn 65, Issue 7, 2013, Pages 970-979

  Berthelsen, Ragna ^a   Nielsen, Carsten Uhd ^a   Brodin, Birger ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

basolateral peptide transporter; drug delivery; intestinal epithelium; proton coupled peptide transporter

Indexed keywords

4 AMINOHIPPURIC ACID; ARGININE; GLYCYLSARCOSINE; LIDOCAINE; NIGERICIN;

ACTIVE TRANSPORT; ANIMAL CELL; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CELL PH; CELL STRAIN CACO 2; CONTROLLED STUDY; ENZYME SPECIFICITY; MICHAELIS MENTEN KINETICS; NONHUMAN; PROTEIN TRANSPORT; PROTON TRANSPORT;

BIOLOGICAL TRANSPORT; CACO-2 CELLS; DIPEPTIDES; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINES; MEMBRANE TRANSPORT PROTEINS; NIGERICIN; SUBSTRATE SPECIFICITY;

EID: 84878792462     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12061     Document Type: Article

References (31)

1. Brodin B, et al. Transport of peptidomimetic drugs by the intestinal Di/tri-peptide transporter, PepT1. Pharmacol Toxicol 2002; 90: 285-296.
2. Sala-Rabanal M, et al. Molecular interactions between dipeptides, drugs and the human intestinal H+ -oligopeptide cotransporter hPEPT1. J Physiol 2006; 574: 149-166.
3. Geissler S, et al. The bioactive dipaptide anserine is transported by human proton-coupled peptide transporters. FEBS J 2010; 277: 790-795.
4. Shepherd EJ, et al. Identification of a candidate membrane protein for the basolateral peptide transporter of the rat small intestine. Biochem Biophys Res Commun 2002; 296: 918-922.
5. Irie M, et al. Efflux properties of basolateral peptide transporter in human intestinal cell line Caco-2. Pflugers Arch 2004; 449: 186-194.
6. Dyer J, et al. Glycyl-L-proline transport in rabbit enterocyte basolateral-membrane vesicles. Biochem J 1990; 269: 565-571.
7. Thwaites DT, et al. Transepithelial glycylsarcosine transport in intestinal Caco-2 cells mediated by expression of H+-coupled carriers at both apical and basal membranes. J Biol Chem 1993; 268: 7640-7642.
8. Thwaites DT, et al. H+-coupled dipeptide (glycylsarcosine) transport across apical and basal borders of human intestinal Caco-2 cell monolayers display distinctive characteristics. Biochim Biophys Acta 1993; 1151: 237-245.
9. Inui K, et al. Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolateral membranes. J Pharmacol Exp Ther 1992; 261: 195-201.
10. Saito H, Inui K,. Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2. Am J Physiol 1993; 265: G289-G294.
11. Bravo SA, et al. In-depth evaluation of Gly-Sar transport parameters as a function of culture time in the Caco-2 cell model. Eur J Pharm Sci 2004; 21: 77-86.
12. Pieri M, et al. The apical (hPepT1) and basolateral peptide transport systems of Caco-2 cells are regulated by AMP-activated protein kinase. Am J Physiol 2010; 299: G136-G143.
13. Henderson FD, et al. cAMP-dependent regulation of basolateral glycyl-sarcosine uptake by human intestinal Caco-2 cell monolayers. J Physiol 2003; 549p, PC9.
14. Irie M, et al. Recognition and transport characteristics of nonpeptidic compounds by basolateral peptide transporter in Caco-2 cells. J Pharmacol Exp Ther 2001; 298: 711-717.
15. Terada T, et al. Functional characteristics of basolateral peptide transporter in the human intestinal cell line Caco-2. Am J Physiol 1999; 276: G1435-G1441.
16. Frølund S, et al. δ-aminolevulinic acid is a substrate for the amino acid transport SLC36A1 (hPAT1). Br J Pharmacol 2010; 159: 1339-1353.
17. Cheng Y, Prusoff WH,. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 1973; 22: 3099-3108.
18. Segel IH,. Enzyme Kinetics. New York: Wiley Interscience. John Wiley & Sons, Inc, 1975.
19. Nielsen CU, et al. Epidermal growth factor inhibits glycylsarcosine transport and hPepT1 expression in a human intestinal cell line. Am J Physiol 2001; 281: G191-G199.
20. Chen XZ, et al. Functional roles of histidine and tyrosine residues in the H(+)-peptide transporter PepT1. Biochem Biophys Res Commun 2000; 272: 726-730.
21. Metzner L, et al. Mutational analysis of histidine residues in the human proton-coupled amino acid transporter PAT1. Biochim Biophys Acta 2008; 1778: 1042-1050.
22. Thwaites DT, et al. Direct assessment of dipeptide/H+ symport in intact human intestinal (Caco-2) epithelium: a novel method utilising continuous intracellular pH measurement. Biochem Biophys Res Commun 1993; 194: 432-438.
23. Matsumoto S, et al. Transcellular transport of oral cephalosporins in human intestinal epithelial cells, Caco-2: interaction with dipeptide transport systems in apical and basolateral membranes. J Pharmacol Exp Ther 1994; 270: 498-504.
24. Walker D, et al. Substrate upregulation of the human intestinal peptide transporter, hPepT1. J Physiol 1998; 507: 697-706.
25. Matthews DM,. Intestinal absorption of peptides. Physiol Rev 1973; 55: 537-608.
26. Terada T, et al. Functional expression of a novel peptide transporter in renal basolateral membranes. Am J Physiol 2000; 279: F851-F857.
27. Sugarawara M, et al. Uptake of dipeptide and beta-lactam antibiotics by the basolateral membrane vesicles prepared from rat kidney. Biochim Biophys Acta 2003; 1609: 39-44.
28. Sawada K, et al. Distinct transport characteristics of basolateral peptide transporters between MDCK and Caco-2 cells. Pflugers Arch 2001; 443: 31-37.
29. Robinson D, et al. The apparent dissociation constants of some glucuronides, mercapturic acids and related compounds. Biochem J 1953; 55: 151-155.
30. +-coupled nutrient, micronutrient and drug transporters in the mammalian small intestine. Exp Physiol 2007; 92: 603-619.
31. Lowry M, et al. Metabolism of glycine- and hydroxyproline-containing peptides by the isolated perfused rat kidney. Biochem J 1985; 229: 545-549.